| Parameter | DM (n = 16) | Non-DM (n = 12) | P |
| Age, mean ± SD | 60.7 ± 8.1 | 65.02 ± 10.1 | 0.3 |
| Gender | All men | 0.57 | |
| Smoker, (n), (%) | 10 (35%) | 8 (20.5%) | 0.23 |
| CAD, (n), (%) | 7 | 4 | 0.7 |
| HT, (n), (%) | 11 | 8 | 0.9 |
| COPD, (n), (%) | 2 | 4 | 0.3 |
| CAD history | 8 | 5 | 0.7 |
| Diabeticfoot | 7 | 0 | <0.01 |
| Aspirine | 10 | 8 | 0.4 |
| DMAH | 5 | 3 | 0.9 |
| Clopidogrel | 8 | 6 | 0.9 |
| Femoropopliteal bypass | 7 | 8 | 0.2 |
| Aortobifemoral bypass (ABF) | 4 | 1 | 0.3 |
| İleofemoral bypass | 2 | - | - |
| Pseudoaneurisym | 2 | - | - |
| Redo-femoropopliteal bypass | 1 | - | - |
| Distallimb bypass | - | 1 | - |
| Redo ABF | - | 1 | - |
| Embolectomy | - | 1 | - |
| Preop-ABI | 0.6 (0.52 - 0.8) | 0.5 (0.44 - 0.82) | 0.7 |
| Postop-ABI | 0.6 (0.53 - 0.81) | 0.6 (0.5 - 0.84) | 0.8 |
| X clamptimes. median, IQR | 40 (25 - 45) | 42.5 (25 - 52.5) | 0.5 |
| Postoperativepulses | Inallpalpable | ||